Risedronate Sodium

CHEMBL1654 Phase 4 ได้รับการอนุมัติ Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

305.1 g/mol

LogP

—

Phase

4

The sodium salt formulation of risedronate used to strengthen bones and prevent fractures in osteoporosis, taken weekly or monthly to improve convenience and adherence. It must be taken with plain water while upright and on an empty stomach to ensure proper absorption.

น้ำหนักโมเลกุล

305.0900 g/mol

TPSA

151.00 Å²

ด้านการรักษา

Osteoporosis Epilepsy Lymphoma Breast Cancer Prostate Cancer Leukemia

Pharmacokinetics (PK)

Pharmacodynamics (PD)

โครงสร้าง 2 มิติ

SVG PNG

Cite this structure

Embed this structure

SMILES

O=P([O-])(O)C(O)(Cc1cccnc1)P(=O)(O)O.[Na+]

InChI

InChI=1S/C7H11NO7P2.Na/c9-7(16(10,11)12,17(13,14)15)4-6-2-1-3-8-5-6;/h1-3,5,9H,4H2,(H2,10,11,12)(H2,13,14,15);/q;+1/p-1

Molecular Formula

C7H10NNaO7P2

HBD / HBA

4 / 8

พันธะที่หมุนได้

4

อะตอมหนัก

18

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

The sodium salt formulation of risedronate used to strengthen bones and prevent fractures in osteoporosis, taken weekly or monthly to improve convenience and adherence. It must be taken with plain water while upright and on an empty stomach to ensure proper absorption.

Yes, Risedronate Sodium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1654. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 4194514. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

กำลังมองหาข้อมูลที่เข้าใจง่ายสำหรับผู้ป่วยอยู่ใช่ไหม?

Risedronate Sodium บน PillFYI

โครงสร้าง

ข้อมูลด่วน

สูตร: C7H10NNaO7P2
คำพ้องความหมาย: 2

ลิงก์ภายนอก

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.